Flywheel.io Raises $22M And Buys Out Competition
A series C funding round will enable Flywheel.io to buy out Radiologics and continue development of its clinical trial data management products.
You may also be interested in...
ObvioHealth Is Building A New Digital Ecosystem To 'Revolutionize' Trials
Using artificial intelligence and strict data collection protocol, ObvioHealth hopes to digitize clinical trials with the assistance of medical devices and consumer technology.
The Illumina Shareholder Votes Are In, And Nobody Got What They Wanted
Carl Icahn was successful in ousting Illumina’s chair, however its CEO, Francis deSouza remains. Both analysts and investors believe this could further encourage Illumina to divest Grail.
Execs On The Move: April 2023
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.